Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents
Date of this Version
High out-of-pocket (OOP) costs may limit access to novel oral cancer medications. In a retrospective study, nearly one third of patients whose OOP costs were $100 to $500 and nearly half of patients whose OOP costs were more than $2,000 failed to pick up their new prescription for an oral cancer medication, compared to 10% of patients who were required to pay less than $10 at the time of purchase. Delays in picking up prescriptions were also more frequent among patients facing higher OOP costs.
See Original Study
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 License.
out-of-pocket costs, cancer, prescription, coinsurance, delay, abandonment
View On LDI Website
Citation For This Study
Doshi, Jalpa A., Pengxiang Li, Hairong Huo, Amy R. Pettit, and Katrina A. Armstrong, Association of Patient Out-ofPocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents. Journal of Clinical Oncology. 2017. doi: 10.1200/JCO.2017.74.5091
Date Posted: 22 January 2018